Sarah Pirrie
Cancer Research UK Clinical Trials Unit(GB)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies, Radiopharmaceutical Chemistry and Applications, Prostate Cancer Treatment and Research
Most-Cited Works
- → Addressing overtreatment of screen detected DCIS; the LORIS trial(2015)369 cited
- → The Detection of Hepatocellular Carcinoma Using a Prospectively Developed and Validated Model Based on Serological Biomarkers(2013)326 cited
- → Breast Cancer Index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen—To Offer More? (aTTom) trial(2019)201 cited
- → SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease(2023)125 cited
- → Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both(2016)88 cited
- → Examining the Immunological Effects of COVID-19 Vaccination in Patients with Conditions Potentially Leading to Diminished Immune Response Capacity – The OCTAVE Trial(2021)74 cited
- → Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasive Bladder Cancer: Preliminary Data from the BladderPath Study(2021)63 cited
- → Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA : a 23‐gene panel with utility for non‐invasive diagnosis and risk stratification(2019)57 cited
- → TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancer(2016)54 cited
- → Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM(2015)45 cited